The goal of this observational study is to To assess the prevalence and patterns of dietary supplement use among patients with cancer and to analyze the impact of these supplements in the context of anticancer medical treatments, including chemotherapy, targeted therapies, hormone therapy, and immunotherapies.
The main questions it aims to answer :
* What is the prevalence of dietary supplement use among cancer patients, and what is their tolerance profile? * Are there any potential drug interactions between dietary supplements and anticancer medications?
Participants will:
* Provide sociodemographic information, including age, sex, educational level, and other relevant characteristics. * Report their use of dietary supplements, including the types of supplements consumed (e.g., vitamins, minerals, herbal products), dietary practices, frequency and duration of use, and reasons for consumption (e.g., medical recommendation or self-medication). * Report any perceived adverse effects related to dietary supplement use to assess tolerance. * Allow the collection of relevant clinical data from their medical records, including cancer type, ongoing anticancer treatments, and treatment-related adverse effects.
Patients diagnosed with cancer and receiving medical anticancer treatment, including chemotherapy, hormone therapy, immunotherapy, and targeted therapies.
Current or recent use of one or more dietary supplements (e.g., vitamins, minerals, herbal products, or other nutritional supplements).
Adult patients : >=18
Patients unable to complete the study questionnaire because of cognitive impairment or a deteriorated health condition.
Failure or refusal to provide written informed consent.
Adult patients diagnosed with cancer and receiving medical anticancer treatment (chemotherapy, hormone therapy, immunotherapy, or targeted therapy) at the study site. Participants will be assessed for dietary supplement use, tolerance, and potential interactions between dietary supplements and anticancer medications.
Cohort
Prospective
Dietary Supplement Use Assessment
BehavioralParticipants will complete a structured face-to-face questionnaire on dietary supplement use, reasons for Use, frequency and duration of use, perceived adverse effects, and concomitant anticancer treatments.
Prevalence of Dietary Supplement Use and Tolerance
Assessment of the prevalence of dietary supplement use among cancer patients and evaluation of adverse effects associated with dietary supplement consumption.
Potential Drug-Supplement Interactions
Assessment of potential interactions between dietary supplements and anticancer medications
Potential Drug-Supplement Interactions Assessed by Artificial Intelligence
Assessment of potential interactions between dietary supplements and anticancer treatments using Hedrine software.
Click on the lead sponsor to view all of their trials.